Clinical Trial Update: A Study to Assess Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer Participants After Treatment Decentralization

View source ↗

Summary

This clinical trial update from Hoffmann-La Roche is evaluating treatment patterns and adherence in patients with early-stage HER2-positive breast cancer after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Early-stage HER2+ Breast Cancer | Status: RECRUITING